AGP Executive Report
Last update: 11 hours agoCancer Treatment: The European Commission has authorised Rasonque for adults with metastatic pancreatic cancer after at least one prior systemic treatment. The approval covers Iceland through the European Economic Area, though access depends on national pricing and reimbursement decisions. Antimicrobial Resistance: Drug-resistant infections remain a major European health threat, with about 35,000 deaths a year across the EU, Iceland and Norway. The ECDC warns that resistant Klebsiella infections are rising and calls for stronger hospital infection controls. Mental Health: Landsbankinn donated ISK 4 million to Icelandic organisation Hugarafl, which supports people facing mental health challenges and works to reduce stigma. Climate and Health: A report on emerging disease risks notes that mosquitoes were found in the wild in Iceland for the first time last October, as warming temperatures help infectious diseases spread.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.